Dividends Calendar Earnings Calendar

GTHX | G1 Therapeutics, Inc.

G1 Therapeutics, Inc.
  • Industry: Biotechnology

Quick infos

  • Headquarters:   North Carolina, United States

Trade prices

  • Volume:
  • Market Cap: 220.79M
  • Prev closed:
  • Open: 8.96
  • High: 9.22
  • Low: 8.73
  • 52 week low: 8.04
  • 52 week high: 26.69
  • Dividends:No Dividends

Next ER: November 2, 2022  Before Market Opens



Top Stories (GTHX)

    Company Profile

    Our mission is to discover, develop and deliver innovative therapies that improve the lives of those affected by cancer. Led by a team with a deep understanding of the biology of cancer and extensive drug discovery, development and commercialization experience, we are rapidly advancing two novel therapies for people living with cancer.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    February 22, 2023
    November 9, 2022- / -0.6409- / 23.33M
    August 3, 2022-0.92 / -1.0210.57M / 9.14MBeat!
    May 4, 2022-1.15 / -0.97986.9M / 6.37MBeat!
    February 23, 2022-0.94 / -1.035.8M / 5.71MBeat!
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Aug 3, 2022 8.70 8.86
    9.17
    7.83
    2.43M 4.69%
    Aug 2, 2022 8.31 8.03
    8.45
    8.03
    540.73K 2.21%
    Aug 1, 2022 8.13 8.25
    8.71
    7.98
    1.14M -2.4%
    Jul 29, 2022 8.33 8.25
    8.36
    8.00
    466.13K 0.24%
    Jul 28, 2022 8.31 8.17
    8.31
    7.82
    498.24K 0.85%
    Jul 27, 2022 8.24 8.35
    8.47
    7.95
    652.95K 0.61%
    Jul 26, 2022 8.19 8.10
    8.77
    7.88
    1.21M -0.12%
    Jul 25, 2022 8.20 8.19
    8.36
    8.06
    466.09K 0.12%
    Jul 22, 2022 8.19 8.51
    8.62
    7.96
    573.45K -3.76%
    Jul 21, 2022 8.51 8.12
    8.52
    8.07
    629.49K 4.55%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:2008
    • Employees:104

    News

    News for (GTHX)

    This company doesn't provide a dividend.

    Key Persons

    • Chief Medical Officer :  Raj Malik

    Talk about G1 Therapeutics, Inc. below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on Nov 2, 2022 (Same day)

    ctsh ebay race mgm z el swn qcom epd dnow apa cf 


    Jump to (Finance sites)

    Their Official Profiles 

    TwitterLinkedIn

    Other stocks 

    hpq mmm apc cx wba kr spot rh info five docu gwre 

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    The Intelligent Investor
    Buy on Amazon

    Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.

    The best book on investing ever written.
    -- Warren Buffet